Вы не вошли. Пожалуйста, войдите или зарегистрируйтесь.
Активные темы Темы без ответов
Настройки поиска
India’s rich biodiversity has changed significantly over time, with several remarkable species disappearing due to habitat loss, hunting, environmental changes, and human activities. Learning about five extinct animals in India helps us understand the country’s natural history and the importance of protecting species that remain today. Animals such as the Asiatic cheetah, Indian aurochs, pink-headed duck, Himalayan quail, and Malabar civet are often discussed in conversations about species that have vanished or are considered possibly extinct in the wild. Their stories highlight how fragile ecosystems can become when natural habitats are disturbed. Exploring these species also encourages greater awareness about wildlife conservation, habitat restoration, and responsible environmental practices. Understanding India’s lost wildlife can inspire stronger efforts to protect its diverse animal species for future generations.
I recently came across Visionary Women Leaders of Asia 2026, a feature by The Portfolio Magazine highlighting women leaders creating meaningful impact across Asia’s business landscape. The edition profiles founders, CEOs, and senior executives from sectors including finance, healthcare, technology, manufacturing, retail, and supply chain. What makes the feature interesting is its focus on real leadership decisions, challenges, transformation, and experiences behind professional achievements. Leaders such as Misba Mithwani, Rammya Nair, Roshni Gupta, Tan Soo Ling, and Dr Vidya Nandagopal share perspectives shaped by years of industry experience
Hi everyone,
I've been researching the top 50 pharma companies in India for a market study, and the rankings vary wildly depending on the source. Some rank by revenue, others by export volume or R&D spend.
Sun Pharma, Cipla, Dr. Reddy's and Lupin appear consistently at the top, but the middle order shifts a lot. Mid-cap players like Alkem, Torrent and Mankind have climbed fast in recent years.
What metric do you think matters most — domestic sales, USFDA approvals, or global footprint?
Сообщений найдено 3
Сгенерировано за 0.014 секунды (82% PHP — 18% БД) 5 запросов к базе данных